Nomura Holdings
PRME icon

Nomura Holdings’s Prime Medicine PRME Stock Holding History

Nomura Holdings’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,823
Closed -$86.4K – 1995
2026
Q1 		$86.4K Buy
24,823
+34
+0.1% +$129 ﹤0.01% 1637
2025
Q4 		$86K Sell
24,789
-126
-0.5% -$560 ﹤0.01% 1848
2025
Q3 		$138K Buy
+24,915
New +$101K ﹤0.01% 1798

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Nomura Holdings's PRME Position: Q2 2026 in Review

Nomura Holdings sold out of Prime Medicine (PRME) in Q2 2026, closing a stake of 24,823 shares — an estimated $86.4K sold.

Nomura Holdings first reported a position in PRME in Q3 2025 and held it in 3 quarters. The position peaked at $138K in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Nomura Holdings reported no remaining Prime Medicine position as of Q2 2026 after selling out during the quarter.
  • Nomura Holdings sold 24,823 Prime Medicine shares in Q2 2026, an estimated $86.4K.
  • Nomura Holdings first reported a position in Prime Medicine in Q3 2025 and held it in 3 quarters.
  • Nomura Holdings's Prime Medicine position peaked at $138K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.